Jade Biosciences, Inc.

JBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$13.91-1.07%

2026-11-02

Financials

Valuation Metrics

Jade Biosciences, Inc.'s Market Cap is $885M. At end of 2025 it was $1.09B. Ranked #2475 of 3,118 in US market (top 79%), #1022 of 1,474 on NASDAQ (top 69%), #185 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 70%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$885M	US#2,475/3,118 Sec#185/265
Revenue	$0.00	US#2,858/3,118 Sec#193/265
Net Income	$-153M	US—/3,118 Sec—/265
Total Assets	$472M	US#2,782/3,118 Sec#169/265
Net Assets	$440M	US#2,301/3,118 Sec#120/265
Value
P/B	2.01x	US#1,296/3,118 Sec#65/265
FCF Yield	-13.97%	US—/3,118 Sec—/265
Profitability
ROE	-34.83%	US#2,589/3,118 Sec#123/265
ROA	-32.46%	US#2,893/3,118 Sec#164/265
Financial Health
Debt Ratio	7.32%	US#65/3,118 Sec#32/265
Total Debt	$628000.00	US#2,975/3,118 Sec#247/265
FCF	$-124M	US#2,678/3,118 Sec#163/265
Cash	$107M	US#2,185/3,118 Sec#169/265
Current Ratio	14.93x	US#164/3,118 Sec#49/265
Performance
1Y Return	41.94%	US#600/3,118 Sec#81/265
1M Return	-1.49%	US#1,777/3,118 Sec#118/265
From 52W High	-50.32%	US#2,620/3,118 Sec#195/265
1Y MDD	-50.06%	US#2,397/3,118 Sec#162/265
Trading
Volume	597,859 shares	US#1,825/3,118 Sec#180/265
Trading Value	$8M	US#2,303/3,118 Sec#178/265
Per Share
EPS	$-2.41	US—/3,118 Sec—/265
BPS	$6.92	US#2,095/3,118 Sec#100/265